Format

Send to

Choose Destination
Arch Pharm Res. 2011 Jun;34(6):865-7. doi: 10.1007/s12272-011-0621-2.

Novel botanical drug for the treatment of diabetic neuropathy.

Author information

1
Research Center of Dong-A Pharm Co., Ltd, Yongin 446-905, Korea.

Abstract

Diabetic neuropathy has multiple aspects of pathophysiology including metabolic derangements and alterations of microvessel with hyperglycemia. Currently, there is no effective long-term treatment based on the pathologic mechanisms. Nerve regeneration with nerve growth factor (NGF) has been on clinical trials as a treatment option. This article reviews an action of a herbal medicine, DA 9801, whose mechanism of action is related to NGF in treating diabetic neuropathy.

PMID:
21660513
DOI:
10.1007/s12272-011-0621-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center